Bristol Historical Financial Ratios

BMY Stock  USD 54.23  0.98  1.84%   
Bristol Myers is presently reporting on over 111 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Price Earnings Ratio of 19.89, Price To Sales Ratio of 2.98 or Dividend Yield of 0.0374 will help investors to properly organize and evaluate Bristol-Myers Squibb financial condition quickly.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bristol Myers Squibb. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

About Bristol Financial Ratios Analysis

Bristol-Myers SquibbFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Bristol Myers investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Bristol financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Bristol Myers history.

Bristol Myers Financial Ratios Chart

Bristol Myers Squibb financial ratios usually calculated using numerical values taken directly from Bristol Myers financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about Bristol Myers. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.
At this time, Bristol Myers' Payables Turnover is fairly stable compared to the past year. Long Term Debt To Capitalization is likely to rise to 0.59 in 2024, whereas Short Term Coverage Ratios is likely to drop 4.01 in 2024.

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Bristol-Myers Squibb stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Bristol Myers sales, a figure that is much harder to manipulate than other Bristol Myers Squibb multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is Bristol Myers Squibb dividend as a percentage of Bristol Myers stock price. Bristol-Myers Squibb dividend yield is a measure of Bristol Myers stock productivity, which can be interpreted as interest rate earned on an Bristol Myers investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.
Most ratios from Bristol Myers' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Bristol-Myers Squibb current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bristol Myers Squibb. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
At this time, Bristol Myers' Payables Turnover is fairly stable compared to the past year. Long Term Debt To Capitalization is likely to rise to 0.59 in 2024, whereas Short Term Coverage Ratios is likely to drop 4.01 in 2024.
 2021 2022 2023 2024 (projected)
Dividend Yield0.03170.030.04470.0374
Price To Sales Ratio2.993.342.362.98

Bristol Myers fundamentals Correlations

-0.02-0.060.22-0.35-0.090.160.37-0.260.0-0.230.050.270.020.1-0.390.240.05-0.11-0.3-0.12-0.370.690.070.0-0.37
-0.020.65-0.440.220.7-0.560.39-0.430.96-0.450.460.3-0.120.67-0.46-0.380.770.03-0.23-0.32-0.25-0.06-0.240.96-0.34
-0.060.65-0.740.170.64-0.590.56-0.610.47-0.630.76-0.01-0.180.45-0.54-0.70.28-0.11-0.26-0.27-0.31-0.2-0.380.47-0.42
0.22-0.44-0.74-0.2-0.390.42-0.070.57-0.280.58-0.610.090.09-0.31-0.010.79-0.410.170.340.110.350.40.33-0.280.39
-0.350.220.17-0.2-0.16-0.19-0.02-0.080.22-0.090.130.2-0.810.320.030.020.23-0.040.010.140.02-0.32-0.250.220.01
-0.090.70.64-0.39-0.16-0.390.24-0.390.62-0.420.530.210.120.45-0.27-0.430.44-0.27-0.18-0.42-0.190.050.10.62-0.24
0.16-0.56-0.590.42-0.19-0.39-0.220.11-0.430.13-0.480.180.05-0.230.30.51-0.19-0.22-0.130.09-0.10.410.42-0.43-0.02
0.370.390.56-0.07-0.020.24-0.22-0.420.37-0.40.160.12-0.270.39-0.94-0.230.040.06-0.23-0.32-0.310.19-0.310.37-0.42
-0.26-0.43-0.610.57-0.08-0.390.11-0.42-0.431.0-0.7-0.30.31-0.590.280.4-0.410.490.90.70.93-0.21-0.01-0.430.94
0.00.960.47-0.280.220.62-0.430.37-0.43-0.450.340.39-0.180.7-0.41-0.240.80.01-0.32-0.43-0.330.01-0.141.0-0.4
-0.23-0.45-0.630.58-0.09-0.420.13-0.41.0-0.45-0.72-0.330.3-0.610.270.39-0.440.50.890.690.92-0.22-0.03-0.450.93
0.050.460.76-0.610.130.53-0.480.16-0.70.34-0.720.06-0.220.4-0.15-0.490.23-0.25-0.47-0.49-0.51-0.12-0.20.34-0.52
0.270.3-0.010.090.20.210.180.12-0.30.39-0.330.06-0.190.82-0.220.50.63-0.48-0.42-0.16-0.410.670.510.39-0.42
0.02-0.12-0.180.09-0.810.120.05-0.270.31-0.180.3-0.22-0.19-0.310.140.05-0.020.170.260.240.280.120.26-0.180.26
0.10.670.45-0.310.320.45-0.230.39-0.590.7-0.610.40.82-0.31-0.430.020.76-0.41-0.56-0.37-0.560.320.20.7-0.62
-0.39-0.46-0.54-0.010.03-0.270.3-0.940.28-0.410.27-0.15-0.220.14-0.430.09-0.1-0.130.080.190.16-0.30.28-0.410.3
0.24-0.38-0.70.790.02-0.430.51-0.230.4-0.240.39-0.490.50.050.020.09-0.040.040.180.210.190.530.46-0.240.25
0.050.770.28-0.410.230.44-0.190.04-0.410.8-0.440.230.63-0.020.76-0.1-0.04-0.16-0.39-0.17-0.380.180.080.8-0.41
-0.110.03-0.110.17-0.04-0.27-0.220.060.490.010.5-0.25-0.480.17-0.41-0.130.04-0.160.620.240.59-0.47-0.740.010.57
-0.3-0.23-0.260.340.01-0.18-0.13-0.230.9-0.320.89-0.47-0.420.26-0.560.080.18-0.390.620.690.99-0.37-0.27-0.320.97
-0.12-0.32-0.270.110.14-0.420.09-0.320.7-0.430.69-0.49-0.160.24-0.370.190.21-0.170.240.690.69-0.14-0.07-0.430.66
-0.37-0.25-0.310.350.02-0.19-0.1-0.310.93-0.330.92-0.51-0.410.28-0.560.160.19-0.380.590.990.69-0.39-0.21-0.330.98
0.69-0.06-0.20.4-0.320.050.410.19-0.210.01-0.22-0.120.670.120.32-0.30.530.18-0.47-0.37-0.14-0.390.580.01-0.41
0.07-0.24-0.380.33-0.250.10.42-0.31-0.01-0.14-0.03-0.20.510.260.20.280.460.08-0.74-0.27-0.07-0.210.58-0.14-0.17
0.00.960.47-0.280.220.62-0.430.37-0.431.0-0.450.340.39-0.180.7-0.41-0.240.80.01-0.32-0.43-0.330.01-0.14-0.4
-0.37-0.34-0.420.390.01-0.24-0.02-0.420.94-0.40.93-0.52-0.420.26-0.620.30.25-0.410.570.970.660.98-0.41-0.17-0.4
Click cells to compare fundamentals

Bristol Myers Account Relationship Matchups

Bristol Myers fundamentals Accounts

201920202021202220232024 (projected)
Short Term Coverage Ratios2.325.613.172.974.224.01
Price Earnings Ratio17.1431.82(15.57)24.3913.2319.89
Price To Sales Ratio4.193.292.993.342.362.98
Operating Cycle301.26137.28175.42194.43214.66226.13
Price Book Value Ratio2.123.73.854.973.616.92
Price Earnings To Growth Ratio(0.95)0.0524(0.11)(2.83)0.430.45
Days Of Payables Outstanding110.4884.11108.29109.46111.2491.58
Operating Cash Flow Per Share4.736.227.36.096.77.03
Dividend Payout Ratio0.530.78(0.45)0.630.730.59
Price To Operating Cash Flows Ratio13.579.978.5411.817.667.28
Free Cash Flow Per Share4.245.896.865.576.116.42
Price To Free Cash Flows Ratio15.1410.539.0912.928.398.81
Pretax Profit Margin0.250.270.19(0.16)0.170.23
Inventory Turnover1.885.684.744.334.022.54
Ebt Per Ebit0.91(1.34)0.80.750.490.47
Payables Turnover3.34.343.373.333.283.81
Effective Tax Rate0.3(0.31)0.130.180.04740.045
Company Equity Multiplier2.523.133.043.123.231.83
Long Term Debt To Capitalization0.460.570.530.540.560.59
Cash Per Share9.037.017.754.315.946.23
Total Debt To Capitalization0.340.480.580.560.570.61
Interest Coverage8.333.617.628.3814.7920.34
Return On Capital Employed0.570.04890.05160.120.240.29
Payout Ratio0.530.78(0.45)0.630.730.59
Debt Equity Ratio0.921.371.271.311.411.48
Dividend Paid And Capex Coverage Ratio4.384.234.733.723.923.39
Net Income Per E B T0.820.691.310.860.950.64
Cash Ratio0.670.760.640.420.510.5
Cash Conversion Cycle190.7953.1767.1384.97103.41107.02
Operating Cash Flow Sales Ratio0.260.310.330.350.280.17
Days Of Inventory Outstanding193.9864.376.9384.2290.87143.64
Days Of Sales Outstanding107.2972.9898.49110.21123.79129.98
Free Cash Flow Operating Cash Flow Ratio0.840.90.950.940.910.61
Cash Flow Coverage Ratios0.660.810.170.360.320.33
Price To Book Ratio2.123.73.854.973.616.92
Current Ratio5.221.61.581.251.431.96

Bristol Myers Investors Sentiment

The influence of Bristol Myers' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Bristol. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Bristol Myers' public news can be used to forecast risks associated with an investment in Bristol. The trend in average sentiment can be used to explain how an investor holding Bristol can time the market purely based on public headlines and social activities around Bristol Myers Squibb. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Bristol Myers' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Bristol Myers' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Bristol Myers' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Bristol Myers.

Bristol Myers Implied Volatility

    
  21.09  
Bristol Myers' implied volatility exposes the market's sentiment of Bristol Myers Squibb stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Bristol Myers' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Bristol Myers stock will not fluctuate a lot when Bristol Myers' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bristol Myers in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bristol Myers' short interest history, or implied volatility extrapolated from Bristol Myers options trading.

Pair Trading with Bristol Myers

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bristol Myers position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bristol Stock

  0.7MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr

Moving against Bristol Stock

  0.62MBIO Mustang Bio Report 3rd of April 2024 PairCorr
  0.59KA Kineta Inc Financial Report 9th of May 2024 PairCorr
  0.46ME 23Andme HoldingPairCorr
The ability to find closely correlated positions to Bristol Myers could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bristol Myers when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bristol Myers - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bristol Myers Squibb to buy it.
The correlation of Bristol Myers is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bristol Myers moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bristol-Myers Squibb moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bristol Myers can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Bristol-Myers Squibb offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bristol Myers' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bristol Myers Squibb Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bristol Myers Squibb Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bristol Myers Squibb. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Bristol Stock analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Money Managers
Screen money managers from public funds and ETFs managed around the world
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Is Bristol Myers' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bristol Myers. If investors know Bristol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bristol Myers listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.09)
Dividend Share
2.31
Earnings Share
3.93
Revenue Per Share
21.753
Quarterly Revenue Growth
0.006
The market value of Bristol-Myers Squibb is measured differently than its book value, which is the value of Bristol that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol Myers' value that differs from its market value or its book value, called intrinsic value, which is Bristol Myers' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol Myers' market value can be influenced by many factors that don't directly affect Bristol Myers' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol Myers' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bristol Myers is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol Myers' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.